Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
automated insulin delivery technology, received approval for use with the ultra-rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) from Eli Lilly, in the European Union (EU). This clearance follows the EU's general authorisation of Lyumjev for insulin pump usage in 2020, which necessitates individual compatibility testing for each pump and AID system. To achieve this compatibility, Tandem and Eli Lilly conducted clinical trials to demonstrate the benefits of using Lyumjev with the Control-IQ technology. The collaboration between the two companies extends beyond the EU, as they aim to secure Lyumjev compatibility for the t:slim X2 pump in additional regions and for the Tandem Mobi pump. Tandem Diabetes Care chief medical officer Dr Jordan Pinsker said: “High satisfaction and quality of life benefits were recently shown in a clinical study using Lyumjev with Control-IQ technology. “Ultra-rapid acting insulin is a popular choice for people living with diabetes due to
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.MarketBeat
- Why Tandem Diabetes Care Stock Thrashed the Market Today [Yahoo! Finance]Yahoo! Finance
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European UnionBusiness Wire
- Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- New Launches Support Tandem Diabetes Stock Despite Macro Concerns [Yahoo! Finance]Yahoo! Finance
TNDM
Earnings
- 8/1/24 - Beat
TNDM
Sec Filings
- 9/18/24 - Form 4
- 9/9/24 - Form SC
- 8/19/24 - Form 4
- TNDM's page on the SEC website